ENSC Ensysce Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$0.40
· of 52w range
· above low
· to high
$0.2352w low
$2.7552w high
Market Cap (MRQ)
$6M
P/E (TTM)
-0.2
EPS (TTM)
$-2.52
Revenue (TTM)
$5M
your badges
52W Range
$0–$3
Analyst Rating
BUY
Price Target
$8
P/E
-0.2
ROE
-968.4%
Net Profit Margin
-280.5%
Your badge strip is empty — pin a metric anywhere on this page.
ENSC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.40
Market Cap (MRQ)
$6M
P/E (TTM)
-0.2
EPS (TTM)
$-2.52
Revenue (TTM)
$5M
ROE (TTM)
-968.4%
Debt/Equity (MRQ)
-0.3
52W Range
$0–$3
ENSC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Dec. 6, 2024 | 1-for-15 | Reverse |
| March 31, 2023 | 1-for-12 | Reverse |
| Oct. 28, 2022 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$5M2020-12-31 → 2025-12-31
EPS$-3.982020-12-31 → 2025-12-31
Free Cash Flow$-8M2025-12-31 → 2025-12-31
Net margin-280.5%2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ENSC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -0.25Y avg ≈-2286.9 | ≈-2286.9 | · | · | |
| P/S (TTM) | 1.45Y avg ≈23689.6 | ≈23689.6 | · | · | |
| P/B (MRQ) | -8.25Y avg ≈-10661.9 | ≈-10661.9 | · | · | |
| EV / EBITDA | 0.25Y avg ≈-4205.1 | ≈-4205.1 | · | · | |
| Price / FCF | -0.2 | · | · | · | |
| Price / Cash Flow | -0.25Y avg ≈-10128.8 | ≈-10128.8 | · | · | |
| EV / Revenue | -0.45Y avg ≈23689.4 | ≈23689.4 | · | · | |
| EV / FCF | 0.3 | · | · | · | |
| Price / Tangible Book | 0.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ENSC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -281.3%5Y avg ≈-466.9% | ≈-466.9% | -4602.1% | Top tier | |
| EBITDA Margin | -202.1%5Y avg ≈-466.9% | ≈-466.9% | -4541.0% | Top tier | |
| Net Profit Margin (TTM) | -280.5%5Y avg ≈-523.1% | ≈-523.1% | -4520.6% | Top tier | |
| ROA (TTM) | -295.9%5Y avg ≈-232.1% | ≈-232.1% | -134.9% | Weak | |
| ROE (TTM) | -968.4%5Y avg ≈117.1% | ≈117.1% | -296.1% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ENSC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | -0.35Y avg ≈-1.0 | ≈-1.0 | · | · | |
| Current Ratio (MRQ) | 0.75Y avg ≈1.2 | ≈1.2 | 2.1 | Low liquidity | |
| Quick Ratio | 0.95Y avg ≈0.8 | ≈0.8 | 1.4 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ENSC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -2.8%5Y avg ≈16.1% | ≈16.1% | · | · | |
| Revenue CAGR 3Y | 26.2%5Y avg ≈7.6% | ≈7.6% | · | · | |
| Revenue CAGR 5Y | 5.2% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ENSC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.85Y avg ≈0.6 | ≈0.6 | · | · | |
| Revenue / Employee | ≈$633.3K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
24.5%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-0.20 | $-0.51 | 60.8% |
| March 31, 2026 | May 15, 2026 | $-0.52 | $-0.74 | 30.2% |
| Dec. 31, 2025 | $-0.75 | $-1.29 | 41.6% | |
| Sept. 30, 2025 | $-1.29 | $-0.88 | -46.2% | |
| June 30, 2025 | $-0.79 | $-1.20 | 34.4% | |
| March 31, 2025 | $-1.39 | $-3.08 | 54.8% | |
| Dec. 31, 2024 | $-2.90 | $-2.79 | -4.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $5M | $5M | $2M | $3M | $4M | $4M | |
| R&D Expense | $10M | $7M | $8M | $20M | $5M | $4M | |
| SG&A Expense | $5M | $5M | $5M | $7M | $19M | $1M | |
| Operating Expenses | $15M | $12M | $13M | $27M | $23M | $6M | |
| Operating Income | $-10M | $-7M | $-11M | $-24M | $-20M | $-2M | |
| Interest Expense | · | · | $353.9K | $109.5K | $1M | $995.5K | |
| Interest Income | · | · | · | · | · | $719.6K | |
| Other Non-op | $73.4K | $17.3K | $15.4K | $86.2K | $-282.3K | · | |
| Pretax Income | · | · | · | · | · | $5M | |
| Net Income | $-10M | $-8M | $-11M | $-24M | $-29M | $-160.9K | |
| EPS (Basic) | $-3.98 | $-11.45 | $-70.40 | $-139.42 | $-29.64 | $0.00 | |
| EPS (Diluted) | $-3.98 | $-11.45 | $-70.40 | $-139.42 | $-1.48 | $0.00 | |
| Shares (Basic) | 2,557,377 | 697,686 | 150,937 | 179,925 | 1,008,227 | 15,768,725 | |
| Shares (Diluted) | 2,557,377 | 697,686 | 150,937 | 179,925 | 20,164,503 | 16,507,387 | |
| EBITDA | $-10M | $-7M | $-11M | $-24M | $-20M | $-1M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $1M | $3M | $12M | $194.2K | |
| Prepaid Expense | $3M | $2M | $1M | $2M | $3M | $157.5K | |
| Other Current Assets | $20.6K | $18.0K | $18.0K | · | · | · | |
| Current Assets | $7M | $5M | $2M | $5M | $16M | $347.9K | |
| PP&E (Net) | $124.1K | · | · | · | · | $151 | |
| Other Non-current Assets | $83.3K | $252.6K | $419.2K | $585.9K | $754.8K | $3.8K | |
| Total Assets | $7M | $6M | $3M | $6M | $16M | $351.8K | |
| Accounts Payable | $3M | $1M | $2M | $3M | $301.1K | $2M | |
| Short-term Debt | $306.7K | $301.7K | $854.7K | $4M | $13M | $4M | |
| Current Liabilities | $5M | $2M | $3M | $9M | $16M | $7M | |
| Other Non-current Liabilities | · | $10.1K | $26.4K | $310.3K | $4M | · | |
| Total Liabilities | $5M | $2M | $3M | $10M | $25M | $7M | |
| Total Debt | $306.7K | $301.7K | $854.7K | $4M | $13M | · | |
| Common Stock | $459 | $136 | $21 | $53 | $124 | $1.6K | |
| Paid-in Capital | $143M | $133M | $121M | $107M | $78M | $50M | |
| Retained Earnings | $-140M | $-130M | $-122M | $-111M | $-86M | $-56M | |
| Stockholders' Equity | $3M | $4M | $-322.9K | $-4M | $-8M | $-6M | |
| Liabilities + Equity | $7M | $6M | $3M | $6M | $16M | $351.8K | |
| Shares Outstanding | 4,574,977 | 1,355,773 | 209,739 | 534,490 | 1,232,160 | 15,768,725 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $177.1K | $110.7K | $879.2K | $1M | $121.8K | $178.7K | |
| Operating Cash Flow | $-8M | $-8M | $-11M | $-18M | $-8M | $-1M | |
| CapEx | $123.6K | · | · | · | · | · | |
| Investing Cash Flow | $-123.6K | · | · | $4.5K | · | $183M | |
| Stock Issued | · | · | · | · | $7M | · | |
| Stock Repurchased | · | · | · | · | · | $185M | |
| Net Stock Activity | · | · | · | · | $7M | $-185M | |
| Financing Cash Flow | $9M | $10M | $9M | $9M | $20M | $1M | |
| Net Change in Cash | $808.3K | $2M | $-2M | $-9M | $12M | $-147.3K | |
| Taxes Paid | $2.5K | $3.2K | $3.2K | $1.6K | $1.6K | $1.6K | |
| Free Cash Flow | $-8M | · | · | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -202.1% | -129.2% | -480.5% | -959.9% | -562.7% | · | |
| Net Margin | -200.9% | -153.3% | -476.4% | -959.3% | -825.4% | · | |
| EBITDA Margin | -202.1% | -129.2% | -480.5% | -959.9% | -562.7% | · | |
| ROA | -156.0% | -192.3% | -247.3% | -217.1% | -347.6% | · | |
| ROE | -294.0% | -471.8% | 526.4% | 417.6% | 407.1% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 2.4 | 0.7 | 0.6 | 1.0 | · | |
| Quick Ratio | 0.9 | 1.6 | 0.3 | 0.3 | 0.7 | · | |
| Debt / Equity | 0.1 | 0.1 | -2.6 | -1.1 | -1.6 | · | |
| Interest Coverage | · | · | -30.3 | -221.2 | -15.3 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.3 | 0.5 | 0.2 | 0.4 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.70 | $2.74 | $-0.10 | $-0.58 | $-0.32 | · | |
| Revenue / Share | $1.98 | $7.47 | $0.99 | · | $0.18 | · | |
| Cash Flow / Share | $-3.05 | $-10.75 | $-4.76 | · | $-0.41 | · | |
| Cash / Share | $0.94 | $2.58 | $0.36 | $0.49 | $0.50 | · | |
| EPS (TTM) | $-3.98 | $-11.45 | $-70.40 | $-139.42 | $-1.48 | $0.00 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.8% | 133.6% | -11.6% | -28.5% | -10.2% | · | |
| Revenue CAGR 3Y | 26.2% | 13.8% | -17.2% | · | · | · | |
| Revenue CAGR 5Y | 5.2% | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $5M | $2M | $3M | $4M | $4M | |
| Net Income TTM | $-10M | $-8M | $-11M | $-24M | $-29M | $-160.9K | |
| Market Cap | $4M | $11M | $50M | $866M | $416.96B | · | |
| Enterprise Value | $205.3K | $8M | $50M | $867M | $416.96B | · | |
| P/E | -0.2 | -0.7 | -0.2 | -1.0 | -11432.4 | · | |
| P/S | 0.8 | 2.1 | 22.4 | 343.2 | 118079.5 | · | |
| P/B | 1.3 | 3.0 | -154.9 | -233.1 | -52925.8 | · | |
| P / Tangible Book | 1.3 | 3.0 | · | · | · | · | |
| P / Cash Flow | -0.5 | -1.5 | -4.6 | -48.4 | -50588.8 | · | |
| P / FCF | -0.5 | · | · | · | · | · | |
| EV / EBITDA | -0.0 | -1.2 | -4.6 | -35.8 | -20984.1 | · | |
| EV / FCF | -0.0 | · | · | · | · | · | |
| EV / Revenue | 0.0 | 1.5 | 22.3 | 343.6 | 118079.6 | · | |
| Earnings Yield | -432.6% | -140.7% | -442.8% | -103.3% | -0.01% | 0.00% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $961.0K | $2M | $493.1K | $1M | $1M | $1M | $3M | $181.8K | $305.7K | $515.0K | $435.4K | $490.5K | $789.6K | $1M | $279.4K | |
| R&D Expense | $2M | $3M | $4M | $3M | $2M | $2M | $4M | $2M | $947.2K | $778.9K | $2M | $2M | $2M | $2M | $7M | $5M | |
| SG&A Expense | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $2M | |
| Operating Expenses | $4M | $5M | $5M | $4M | $3M | $3M | $5M | $3M | $2M | $2M | $4M | $3M | $3M | $3M | $8M | $6M | |
| Operating Income | $-3M | $-4M | $-3M | $-4M | $-2M | $-2M | $-4M | $644.7K | $-2M | $-2M | $-3M | $-3M | $-2M | $-3M | $-6M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $7.6K | · | $1.5K | $51.9K | $4.9K | |
| Other Non-op | $5.8K | $9.7K | $19.2K | $17.3K | $21.0K | $15.9K | $29.7K | $14.7K | $7.4K | $-34.5K | $-8.0K | $6.9K | $11.0K | $5.4K | $66.7K | $8.7K | |
| Net Income | $-3M | $-4M | $-3M | $-4M | $-2M | $-2M | $-4M | $661.8K | $-2M | $-3M | $-4M | $-3M | $-2M | $-2M | $-5M | $-10M | |
| EPS (Basic) | $-0.20 | $-0.52 | $-0.51 | $-1.29 | $-0.79 | $-1.39 | $-0.89 | $1.00 | $-3.35 | $-8.21 | $-66.47 | $-0.87 | $-0.98 | $-2.08 | $-6.69 | $-61.58 | |
| EPS (Diluted) | $-0.20 | $-0.52 | $-0.51 | $-1.29 | $-0.79 | $-1.39 | $-0.89 | $1.00 | $-3.35 | $-8.21 | $-66.47 | $-0.87 | $-0.98 | $-2.08 | $1.48 | $-61.58 | |
| Shares (Basic) | 13,035,632 | 6,839,385 | · | 2,886,059 | 2,202,299 | 1,401,144 | · | 659,361 | 587,822 | 379,634 | · | 3,085,873 | 2,274,113 | 1,054,202 | · | 160,719 | |
| Shares (Diluted) | 13,035,632 | 6,839,385 | · | 2,886,059 | 2,202,299 | 1,401,144 | · | 659,361 | 587,822 | 379,634 | · | 3,085,873 | 2,274,113 | 1,054,202 | · | 160,719 | |
| EBITDA | $-3M | · | · | $-4M | $-2M | $-2M | · | $644.7K | $-2M | $-2M | · | $-3M | $-2M | $-3M | · | $-6M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676.7K | $745.5K | $4M | $2M | $2M | $3M | $4M | $4M | $1M | $3M | $1M | $1M | $4M | $1M | $3M | $5M | |
| Prepaid Expense | $2M | $1M | $3M | $1M | $2M | $1M | $2M | $3M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | |
| Other Current Assets | $20.6K | $25.5K | $18.0K | $68.1K | $241.0K | $222.7K | $18.0K | $18.0K | $64.4K | $25.5K | $18.0K | $8.0K | · | · | · | · | |
| Current Assets | $3M | $2M | $7M | $3M | $5M | $4M | $5M | $9M | $2M | $5M | $2M | $3M | $6M | $3M | $5M | $8M | |
| PP&E (Net) | $111.1K | $117.6K | $124.1K | $123.6K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | $41.7K | $85.9K | $127.6K | $292.9K | $210.9K | $252.6K | $294.2K | $335.9K | $377.6K | $419.2K | $460.9K | $502.6K | $544.2K | $585.9K | $627.5K | |
| Total Assets | $3M | $2M | $7M | $3M | $6M | $5M | $6M | $9M | $3M | $5M | $3M | $3M | $6M | $4M | $6M | $8M | |
| Accounts Payable | $2M | $2M | $3M | $463.5K | $1M | $615.3K | $1M | $2M | $482.0K | $981.7K | $2M | $916.4K | $1M | $2M | $3M | $1M | |
| Short-term Debt | $196.8K | $245.8K | $306.7K | $387.7K | $424.5K | $257.4K | $301.7K | $387.2K | $454.5K | $246.0K | $854.7K | $350.9K | $445.7K | · | $4M | $8M | |
| Current Liabilities | $4M | $3M | $5M | $2M | $3M | $2M | $2M | $3M | $1M | $2M | $3M | $2M | $3M | $4M | $9M | $12M | |
| Other Non-current Liabilities | · | · | · | $35 | $1.0K | $130.2K | $10.1K | · | · | · | $26.4K | · | · | · | $310.3K | $1M | |
| Total Liabilities | $4M | $3M | $5M | $2M | $3M | $2M | $2M | $3M | $1M | $2M | $3M | $2M | $3M | $4M | $10M | $15M | |
| Total Debt | $196.8K | · | · | $387.7K | $424.5K | $257.4K | · | $387.2K | $454.5K | $246.0K | · | $350.9K | $445.7K | · | · | $8M | |
| Common Stock | $1.6K | $929 | $459 | $320 | $241 | $165 | $136 | $1.4K | $815 | $733 | $21 | $287 | $267 | $128 | $53 | $221 | |
| Paid-in Capital | $145M | $143M | $143M | $138M | $137M | $135M | $133M | $133M | $128M | $128M | $121M | $120M | $119M | $113M | $107M | $99M | |
| Retained Earnings | $-146M | $-143M | $-140M | $-137M | $-133M | $-131M | $-130M | $-126M | $-127M | $-125M | $-122M | $-118M | $-115M | $-113M | $-111M | $-105M | |
| Stockholders' Equity | $-781.7K | $-340.0K | $3M | $1M | $3M | $3M | $4M | $7M | $2M | $4M | $-322.9K | $1M | $4M | $166.7K | $-4M | $-6M | |
| Liabilities + Equity | $3M | $2M | $7M | $3M | $6M | $5M | $6M | $9M | $3M | $5M | $3M | $3M | $6M | $4M | $6M | $8M | |
| Shares Outstanding | 16,227,518 | 9,277,819 | 4,574,977 | 3,181,074 | 2,393,256 | 1,644,728 | 1,355,773 | 13,870,510 | 8,151,172 | 7,329,172 | 209,739 | 2,864,004 | 2,669,792 | 1,284,583 | 534,490 | 2,207,458 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1.9K | $8.7K | $24.3K | $45.9K | $90.6K | $16.3K | $30.1K | $20.8K | $26.5K | $33.2K | $628.9K | $55.7K | $77.4K | $117.1K | $216.7K | $157.1K | |
| Operating Cash Flow | $-2M | $-4M | $-2M | $-2M | $-3M | $-2M | $-764.1K | $-1M | $-2M | $-3M | $-2M | $-2M | $-3M | $-4M | $-3M | $-7M | |
| CapEx | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Stock Issued | · | · | · | $-400.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $-63.9K | $4M | $1M | $2M | $1M | $112.6K | $4M | $-51.2K | $6M | $1M | $-102.5K | $6M | $2M | $2M | $7M | |
| Net Change in Cash | $-68.8K | $-4M | $3M | $-538.4K | $-840.9K | $-449.6K | $-651.5K | $3M | $-2M | $2M | $-340.8K | $-2M | $2M | $-2M | $-1M | $768.4K | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -221.3% | · | · | -758.7% | -127.6% | -149.1% | · | 18.9% | -1075.6% | -602.8% | · | -621.8% | -467.7% | -324.4% | · | -2206.3% | |
| Net Margin | -220.8% | · | · | -756.3% | -126.4% | -147.4% | · | 19.4% | -1082.4% | -1019.4% | · | -618.0% | -456.6% | -277.6% | · | -3528.0% | |
| EBITDA Margin | -221.3% | · | · | -758.7% | -127.6% | -149.1% | · | 18.9% | -1075.6% | -602.8% | · | -621.8% | -467.7% | -324.4% | · | -2206.3% | |
| ROA | -60.3% | · | · | -59.4% | -41.4% | -40.2% | · | 10.5% | -43.0% | -69.3% | · | -46.8% | -31.3% | -26.9% | · | -109.5% | |
| ROE | -197.2% | · | · | -92.0% | -66.7% | -57.2% | · | 15.8% | -66.4% | -159.2% | · | 116.8% | -123.5% | -281.4% | · | 317.9% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | · | · | 1.3 | 2.1 | 2.5 | · | 3.2 | 1.9 | 2.9 | · | 1.4 | 2.3 | 0.8 | · | 0.6 | |
| Quick Ratio | 0.2 | · | · | 0.7 | 0.9 | 1.7 | · | 1.5 | 0.8 | 2.1 | · | 0.7 | 1.5 | 0.4 | · | 0.4 | |
| Debt / Equity | -0.3 | · | · | 0.3 | 0.1 | 0.1 | · | 0.1 | 0.3 | 0.1 | · | 0.2 | 0.1 | · | · | -1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -1.5 | · | -353.9 | · | -1710.9 | · | -1268.4 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | · | · | 0.1 | 0.3 | 0.3 | · | 0.5 | 0.0 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.05 | · | · | $0.38 | $1.42 | $1.85 | · | $0.50 | $0.22 | $0.51 | · | $0.52 | $1.54 | $0.13 | · | $-2.76 | |
| Revenue / Share | $0.09 | · | · | $0.17 | $0.62 | $0.94 | · | $0.35 | $0.02 | $0.05 | · | $0.14 | $0.22 | · | · | · | |
| Cash Flow / Share | · | · | · | · | · | $-1.22 | · | · | · | $-0.60 | · | · | · | · | · | · | |
| Cash / Share | $0.04 | · | · | $0.53 | $0.92 | $1.86 | · | $0.30 | $0.13 | $0.46 | · | $0.51 | $1.43 | $1.10 | · | $2.04 | |
| EPS (TTM) | $-2.52 | $-3.99 | · | $-4.36 | $-2.07 | $-4.63 | · | $-77.03 | $-78.90 | $-76.53 | · | $-2.45 | $-63.16 | $-118.67 | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $4M | · | $4M | $7M | $6M | · | $4M | $1M | $2M | · | $3M | $3M | $3M | · | $3M | |
| Net Income TTM | $-13M | $-11M | · | $-11M | $-7M | $-7M | · | $-8M | $-11M | $-12M | · | $-13M | $-20M | $-25M | · | $-29M | |
| Market Cap | $5M | · | · | $8M | $5M | $4M | · | $50M | $62M | $87M | · | $59M | $72M | $94M | · | $1.71B | |
| Enterprise Value | $4M | · | · | $6M | $4M | $1M | · | $46M | $61M | $84M | · | $58M | $69M | · | · | $1.71B | |
| P/E | -0.1 | -0.1 | · | -0.5 | -1.1 | -0.6 | · | -0.0 | -0.1 | -0.2 | · | -8.4 | -0.4 | -0.6 | · | · | |
| P/S | 1.0 | · | · | 1.7 | 0.7 | 0.7 | · | 11.3 | 43.0 | 49.7 | · | 18.8 | 24.1 | 34.6 | · | 627.0 | |
| P/B | -6.0 | · | · | 6.3 | 1.6 | 1.4 | · | 7.2 | 34.2 | 23.2 | · | 39.9 | 17.5 | 561.7 | · | -280.3 | |
| P / Tangible Book | · | · | · | 6.3 | 1.6 | 1.4 | · | 7.2 | 34.2 | 23.2 | · | 39.9 | 17.5 | 561.7 | · | · | |
| P / Cash Flow | · | · | · | · | · | -2.5 | · | · | · | -25.5 | · | · | · | -26.0 | · | · | |
| EV / Revenue | 0.9 | · | · | 1.4 | 0.5 | 0.2 | · | 10.4 | 42.6 | 47.9 | · | 18.5 | 23.0 | · | · | 628.1 | |
| Earnings Yield | -869.0% | -740.3% | · | -184.0% | -92.8% | -180.9% | · | -2139.7% | -1039.5% | -645.8% | · | -11.8% | -233.9% | -162.8% | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $5M | $5M | $2M | $3M | $4M |
| Operating Margin % | -202.1% | -129.2% | -480.5% | -959.9% | -562.7% |
| Net Income | $-10M | $-8M | $-11M | $-24M | $-29M |
| Diluted EPS | $-3.98 | $-11.45 | $-70.40 | $-139.42 | $-1.48 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.1 | 0.1 | -2.6 | -1.1 | -1.6 |
| Current Ratio | 1.6 | 2.4 | 0.7 | 0.6 | 1.0 |
| Quick Ratio | 0.9 | 1.6 | 0.3 | 0.3 | 0.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-8M | · | · | · | · |
Institutional owners (13F) 19 filers · $252K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
19
Value held
$252K
New positions
5
Exited positions
2
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-1 vs prior Q) | 2 (-4 vs prior Q) | 5 (0 vs prior Q) | 1 (+1 vs prior Q) | +418K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | $60,561 | 208,833 | 24.04% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $43,416 | 149,711 | 17.24% | Shares |
| VANGUARD GROUP INC | $33,772 | 36,708 | 13.41% | Shares |
| PERCEPTIVE ADVISORS LLC | $25,133 | 86,666 | 9.98% | Shares |
| CITADEL ADVISORS LLC | $24,996 | 86,193 | 9.92% | Shares |
| XTX Topco Ltd | $22,331 | 77,005 | 8.87% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $18,033 | 62,188 | 7.16% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9,941 | 34,280 | 3.95% | Shares |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | $3,770 | 13,000 | 1.50% | Shares |
| TWO SIGMA SECURITIES, LLC | $3,756 | 12,953 | 1.49% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $3,728 | 12,854 | 1.48% | Shares |
| Tower Research Capital LLC (TRC) | $1,767 | 6,094 | 0.70% | Shares |
| BARCLAYS PLC | $418 | 1,440 | 0.17% | Shares |
| SBI Securities Co., Ltd. | $186 | 641 | 0.07% | Shares |
| Virtu Financial LLC | $28 | 95,391 | 0.01% | Shares |
| BlackRock, Inc. | $19 | 65 | 0.01% | Shares |
| HRT FINANCIAL LP | $15 | 54,429 | 0.01% | Shares |
| FNY Investment Advisers, LLC | $0 | 3,000 | 0.00% | Shares |
| Clear Street Group Inc. | $0 | 1 | 0.00% | Shares |
Activists & 5%+ owners 6 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Bob Gene Gower | Aug. 18, 2026 | 6.10% | Amendment | M&A / sale | SEC |
| Bob G. Gower ×2 filings | July 18, 2023 | · | Initial filing | Passive investment | SEC |
| MLCP GLL Funding LLC, Matthews Lane Capital Partners LLC, Daniel B. Silvers ×3 filings | July 7, 2022 | · | Initial filing | · | SEC |
| Lynn Kirkpatrick | July 12, 2021 | · | Initial filing | M&A / sale | SEC |
| William Chang | July 12, 2021 | · | Initial filing | M&A / sale | SEC |
| Richard Wright | July 12, 2021 | · | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 18 insiders · 4 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Lynn Kirkpatrick | Chief Executive Officer | Feb. 17, 2022 A | 381,851 | 0 | 0 | $0 |
| David Carl Humphrey | Chief Financial Officer | Feb. 17, 2022 A | 50,000 | 0 | 0 | $0 |
| Kevin Geoffrey Birkett | Chief Commercial Officer | Feb. 17, 2022 A | · | 0 | 0 | $0 |
| Linda Pestano | Chief Development Officer | Feb. 4, 2022 A | · | 0 | 0 | $0 |
| Bob G Gower | Director | April 23, 2026 C | 916,740 | 2 | 0 | $444,135 |
| Curtis Rosebraugh | Director | June 23, 2022 A | · | 0 | 0 | $0 |
| Adam Levin | Director | June 23, 2022 A | · | 0 | 0 | $0 |
| Andrew Benton | Director | June 23, 2022 A | · | 0 | 0 | $0 |
| Lee M. Rauch | Director | June 23, 2022 A | · | 0 | 0 | $0 |
| William H Chang | Director | June 23, 2022 A | 2,242,189 | 0 | 0 | $0 |
| Steven Robert Martin | Director | June 23, 2022 A | · | 0 | 0 | $0 |
| A. Lorne Weil | 10% owner | June 30, 2021 D | · | 0 | 0 | $0 |
| MORGAN STANLEY | 10% owner | June 19, 2020 S | 0 | 0 | 0 | $0 |
| HG Vora Capital Management, LLC | 10% owner | Jan. 15, 2018 J | 3,462,500 | 0 | 0 | $0 |
| Richard Chester Wright | · | June 30, 2021 A | · | 0 | 0 | $0 |
| Eric Carrera | · | June 30, 2021 A | 54,701 | 0 | 0 | $0 |
| George Peng | · | June 30, 2021 A | 87,014 | 0 | 0 | $0 |
| William K Schmidt | · | June 30, 2021 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 12,854 SH | Aug. 19, 2026 | Daily |
ENSC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$8.25
+1988.6%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-09-29Mean target $8.25 +1988.6%
Low$8.25
Mean$8.25
High$8.25
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026